BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10807899)

  • 1. Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration.
    Plauth M; Roske AE; Romaniuk P; Roth E; Ziebig R; Lochs H
    Gut; 2000 Jun; 46(6):849-55. PubMed ID: 10807899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
    Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
    Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The route of administration (enteral or parenteral) affects the conversion of isotopically labeled L-[2-15N]glutamine into citrulline and arginine in humans.
    Ligthart-Melis GC; van de Poll MC; Dejong CH; Boelens PG; Deutz NE; van Leeuwen PA
    JPEN J Parenter Enteral Nutr; 2007; 31(5):343-48; discussion 349-50. PubMed ID: 17712141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial ammonia levels in cirrhosis are determined by systemic and hepatic hemodynamics, and by organ function: a quantitative modelling study.
    Noiret L; Baigent S; Jalan R
    Liver Int; 2014 Jul; 34(6):e45-55. PubMed ID: 24134128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonaemia-induced encephalopathy.
    Vogels BA; van Steynen B; Maas MA; Jörning GG; Chamuleau RA
    J Hepatol; 1997 Feb; 26(2):387-95. PubMed ID: 9059962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy.
    Senzolo M; Zarantonello L; Formentin C; Orlando C; Beltrame R; Vuerich A; Angeli P; Burra P; Montagnese S
    Metab Brain Dis; 2019 Dec; 34(6):1803-1812. PubMed ID: 31506797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal glutamine and ammonia metabolism during chronic hyperammonaemia induced by liver insufficiency.
    Dejong CH; Deutz NE; Soeters PB
    Gut; 1993 Aug; 34(8):1112-9. PubMed ID: 7909784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial.
    Rees CJ; Oppong K; Al Mardini H; Hudson M; Record CO
    Gut; 2000 Oct; 47(4):571-4. PubMed ID: 10986219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy
    Jiang TT; Luo XP; Sun JM; Gao J
    World J Gastroenterol; 2017 Nov; 23(41):7470-7477. PubMed ID: 29151701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Portosystemic shunt via the left branch of portal vein for the prevention of encephalopathy following transjugular intrahepatic portosystemic shunt].
    Chu J; Sun X; Piao L; Chen Z; Huang H; Lu C; Xu J
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):437-40. PubMed ID: 12502447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.
    Olde Damink SW; Jalan R; Redhead DN; Hayes PC; Deutz NE; Soeters PB
    Hepatology; 2002 Nov; 36(5):1163-71. PubMed ID: 12395326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gut does not contribute to systemic ammonia release in humans without portosystemic shunting.
    van de Poll MC; Ligthart-Melis GC; Olde Damink SW; van Leeuwen PA; Beets-Tan RG; Deutz NE; Wigmore SJ; Soeters PB; Dejong CH
    Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G760-5. PubMed ID: 18703642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients.
    Su AP; Cao SS; Le Tian B; Da Zhang Z; Hu WM; Zhang Y; Wang ZL; Babu SR; Hu T
    Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):53-9. PubMed ID: 22099870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The feeding route (enteral or parenteral) affects the plasma response of the dipetide Ala-Gln and the amino acids glutamine, citrulline and arginine, with the administration of Ala-Gln in preoperative patients.
    Melis GC; Boelens PG; van der Sijp JR; Popovici T; De Bandt JP; Cynober L; van Leeuwen PA
    Br J Nutr; 2005 Jul; 94(1):19-26. PubMed ID: 16115328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis.
    Miyaji H; Ito S; Azuma T; Ito Y; Yamazaki Y; Ohtaki Y; Sato F; Hirai M; Kuriyama M; Kohli Y
    Gut; 1997 Jun; 40(6):726-30. PubMed ID: 9245925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral and splanchnic indole and oxindole levels in cirrhotic patients: a study on the pathophysiology of hepatic encephalopathy.
    Riggio O; Mannaioni G; Ridola L; Angeloni S; Merli M; Carlà V; Salvatori FM; Moroni F
    Am J Gastroenterol; 2010 Jun; 105(6):1374-81. PubMed ID: 20125128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory hepatic encephalopathy in a patient with hypothyroidism: Another element in ammonia metabolism.
    Díaz-Fontenla F; Castillo-Pradillo M; Díaz-Gómez A; Ibañez-Samaniego L; Gancedo P; Guzmán-de-Villoria JA; Fernández-García P; Bañares-Cañizares R; García-Martínez R
    World J Gastroenterol; 2017 Jul; 23(28):5246-5252. PubMed ID: 28811719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ammonia uptake by skeletal muscle in the hyperammonaemic rat.
    Hod G; Chaouat M; Haskel Y; Lernau OZ; Nissan S; Mayer M
    Eur J Clin Invest; 1982 Dec; 12(6):445-50. PubMed ID: 6129977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.